Primary biliary cholangitis
Introduction
Primary biliary cholangitis (previously referred to as primary biliary cirrhosis) is a chronic liver disorder typically seen in middle-aged females (female:male ratio of 9:1). The aetiology is not fully understood although it is thought to be an autoimmune condition. Interlobular bile ducts become damaged by a chronic inflammatory process causing progressive cholestasis, which may eventually progress to cirrhosis. The classic presentation is itching in a middle-aged woman.
Epidemiology
- Incidence: 12.00 cases per 100,000 person-years
- Peak incidence: 50-60 years
- Sex ratio: more common in females 8:1
Condition | Relative incidence |
---|---|
Primary biliary cholangitis | 1 |
Primary sclerosing cholangitis | 0.17 |
<1 | 1-5 | 6+ | 16+ | 30+ | 40+ | 50+ | 60+ | 70+ | 80+ |
Aetiology
- Sjogren's syndrome (seen in up to 80% of patients)
- Rheumatoid arthritis
- Systemic sclerosis
- Thyroid disease
Clinical features
- Early: may be asymptomatic (e.g. raised ALP on routine LFTs) or fatigue, pruritus
- Cholestatic jaundice
- Hyperpigmentation, especially over pressure points
- Around 10% of patients have right upper quadrant pain
- Xanthelasmas, xanthomata
- Also: clubbing, hepatosplenomegaly
- Late: may progress to liver failure
Investigations
- Anti-mitochondrial antibodies (AMA) M2 subtype are present in 98% of patients and are highly specific
- Smooth muscle antibodies in 30% of patients
- Raised serum IgM
Management
- Pruritus: cholestyramine
- Fat-soluble vitamin supplementation
- Ursodeoxycholic acid
- Liver transplantation e.g. if bilirubin > 100 (PBC is a major indication) - recurrence in graft can occur but is not usually a problem
Complications
- Cirrhosis
- Osteomalacia and osteoporosis
- Significantly increased risk of hepatocellular carcinoma